ONCOINVENT ASA (ONCIN.OL) Fundamental Analysis & Valuation

OSL:ONCIN • NO0013711713

Current stock price

47.3 NOK
-2.2 (-4.44%)
Last:

This ONCIN.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ONCIN.OL Profitability Analysis

1.1 Basic Checks

  • ONCIN had negative earnings in the past year.
  • ONCIN had a negative operating cash flow in the past year.
  • In the past 5 years ONCIN always reported negative net income.
  • ONCIN had a negative operating cash flow in each of the past 5 years.
ONCIN.OL Yearly Net Income VS EBIT VS OCF VS FCFONCIN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

  • ONCIN has a worse Return On Assets (-160.55%) than 90.20% of its industry peers.
  • ONCIN's Return On Equity of -207.87% is on the low side compared to the rest of the industry. ONCIN is outperformed by 80.39% of its industry peers.
Industry RankSector Rank
ROA -160.55%
ROE -207.87%
ROIC N/A
ROA(3y)-126.61%
ROA(5y)-96.68%
ROE(3y)-201.42%
ROE(5y)-144.62%
ROIC(3y)N/A
ROIC(5y)N/A
ONCIN.OL Yearly ROA, ROE, ROICONCIN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

  • ONCIN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONCIN.OL Yearly Profit, Operating, Gross MarginsONCIN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ONCIN.OL Health Analysis

2.1 Basic Checks

  • ONCIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ONCIN has more shares outstanding
  • Compared to 5 years ago, ONCIN has more shares outstanding
  • ONCIN has a worse debt/assets ratio than last year.
ONCIN.OL Yearly Shares OutstandingONCIN.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
ONCIN.OL Yearly Total Debt VS Total AssetsONCIN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.23, we must say that ONCIN is in the distress zone and has some risk of bankruptcy.
  • ONCIN has a worse Altman-Z score (1.23) than 70.59% of its industry peers.
  • There is no outstanding debt for ONCIN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.23
ROIC/WACCN/A
WACC8.56%
ONCIN.OL Yearly LT Debt VS Equity VS FCFONCIN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.39 indicates that ONCIN has no problem at all paying its short term obligations.
  • ONCIN has a Current ratio of 4.39. This is amongst the best in the industry. ONCIN outperforms 98.04% of its industry peers.
  • A Quick Ratio of 4.39 indicates that ONCIN has no problem at all paying its short term obligations.
  • ONCIN has a Quick ratio of 4.39. This is amongst the best in the industry. ONCIN outperforms 98.04% of its industry peers.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.39
ONCIN.OL Yearly Current Assets VS Current LiabilitesONCIN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ONCIN.OL Growth Analysis

3.1 Past

  • ONCIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.32%, which is quite impressive.
  • ONCIN shows a strong growth in Revenue. In the last year, the Revenue has grown by 139.55%.
  • ONCIN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -37.51% yearly.
EPS 1Y (TTM)70.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6302.86%
Revenue 1Y (TTM)139.55%
Revenue growth 3Y3.09%
Revenue growth 5Y-37.51%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ONCIN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.68% on average per year.
  • Based on estimates for the next years, ONCIN will show a very strong growth in Revenue. The Revenue will grow by 437.17% on average per year.
EPS Next Y99.46%
EPS Next 2Y41.32%
EPS Next 3Y22.68%
EPS Next 5YN/A
Revenue Next Year13900%
Revenue Next 2Y1124.74%
Revenue Next 3Y437.17%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ONCIN.OL Yearly Revenue VS EstimatesONCIN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
ONCIN.OL Yearly EPS VS EstimatesONCIN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1K -2K -3K

More info and screens

Find the best growth stocksShow best growing peers

1

4. ONCIN.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ONCIN. In the last year negative earnings were reported.
  • Also next year ONCIN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONCIN.OL Price Earnings VS Forward Price EarningsONCIN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONCIN.OL Per share dataONCIN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200

4.3 Compensation for Growth

  • ONCIN's earnings are expected to grow with 22.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.32%
EPS Next 3Y22.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ONCIN.OL Dividend Analysis

5.1 Amount

  • No dividends for ONCIN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ONCIN.OL Fundamentals: All Metrics, Ratios and Statistics

ONCOINVENT ASA

OSL:ONCIN (4/24/2026, 7:00:00 PM)

47.3

-2.2 (-4.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-19
Earnings (Next)04-30
Inst Owners38.69%
Inst Owner ChangeN/A
Ins Owners13.1%
Ins Owner ChangeN/A
Market Cap211.90M
Revenue(TTM)848.00K
Net Income(TTM)-139.28M
Analysts86.67
Price Target49.98 (5.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1714.81%
PT rev (3m)1714.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)115.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 249.89
P/FCF N/A
P/OCF N/A
P/B 3.16
P/tB 3.16
EV/EBITDA N/A
EPS(TTM)-240.31
EYN/A
EPS(NY)-0.68
Fwd EYN/A
FCF(TTM)-30.77
FCFYN/A
OCF(TTM)-30.77
OCFYN/A
SpS0.19
BVpS14.96
TBVpS14.96
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -160.55%
ROE -207.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-126.61%
ROA(5y)-96.68%
ROE(3y)-201.42%
ROE(5y)-144.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.39
Altman-Z 1.23
F-Score4
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)282.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)412.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6302.86%
EPS Next Y99.46%
EPS Next 2Y41.32%
EPS Next 3Y22.68%
EPS Next 5YN/A
Revenue 1Y (TTM)139.55%
Revenue growth 3Y3.09%
Revenue growth 5Y-37.51%
Sales Q2Q%N/A
Revenue Next Year13900%
Revenue Next 2Y1124.74%
Revenue Next 3Y437.17%
Revenue Next 5YN/A
EBIT growth 1Y21.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.76%
EBIT Next 3Y2.38%
EBIT Next 5YN/A
FCF growth 1Y51.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.13%
OCF growth 3YN/A
OCF growth 5YN/A

ONCOINVENT ASA / ONCIN.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ONCOINVENT ASA (ONCIN.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ONCIN.OL.


What is the valuation status of ONCOINVENT ASA (ONCIN.OL) stock?

ChartMill assigns a valuation rating of 1 / 10 to ONCOINVENT ASA (ONCIN.OL). This can be considered as Overvalued.


How profitable is ONCOINVENT ASA (ONCIN.OL) stock?

ONCOINVENT ASA (ONCIN.OL) has a profitability rating of 0 / 10.


What is the earnings growth outlook for ONCOINVENT ASA?

The Earnings per Share (EPS) of ONCOINVENT ASA (ONCIN.OL) is expected to grow by 99.46% in the next year.